SCHOTT Pharma AG & Co. KGaA – Trademark Portfolio
Entity Type: 99
SCHOTT Pharma AG & Co. KGaA holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 21 (Housewares) across 5 Nice Classification classes. Currently, 4 trademarks are registered and 6 are pending. Notable registered marks include EVERIC, PHARMAVERSITY, and BECAUSE HUMAN HEALTH MATTERS.
Hattenbergstrasse 10
55122 Mainz
Showing of trademarks Trademarks
Trademark Classifications
SCHOTT Pharma AG & Co. KGaA's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SCHOTT Pharma AG & Co. KGaA have?
SCHOTT Pharma AG & Co. KGaA has 12 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 pending, 2 abandoned.
What trademark classes does SCHOTT Pharma AG & Co. KGaA file in?
SCHOTT Pharma AG & Co. KGaA files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 21 (Housewares), Class 20 (Furniture), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SCHOTT Pharma AG & Co. KGaA's most well-known trademarks?
SCHOTT Pharma AG & Co. KGaA's registered trademark portfolio includes well-known marks such as EVERIC, PHARMAVERSITY, and BECAUSE HUMAN HEALTH MATTERS. These are among 4 currently registered trademarks in the portfolio.
What is SCHOTT Pharma AG & Co. KGaA's trademark registration success rate?
SCHOTT Pharma AG & Co. KGaA has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 6 applications are pending review.